Quidel Corporation Triple Winner in International MarCom Awards Competition
November 10 2020 - 10:00AM
Business Wire
Quidel Corporation has been honored with three awards for
creative excellence from the international MarCom Awards
competition, just announced. Quidel is the diagnostic health care
manufacturer behind the industry’s most rapid and reliable
in-office test for Lyme disease, the Sofia® 2 Lyme FIA test.
The MarCom Awards is an international creative competition that
recognizes outstanding achievement by marketing and communications
professionals, both corporate and agency. Quidel was cited for
excellence while competing against more than 6,500 entries from the
United States and several foreign countries.
Quidel was presented with MarCom’s highest honor—a Platinum
Award—for its soon-to-launch consumer-facing website titled “Lyme
Disease Answers.” Created in tandem with its strategic and creative
partner breakwhitelight, the website will provide consumers with
the peace of mind that comes with increased knowledge of the
prevalence, causes, warning signs and symptoms of Lyme disease as
well as important information regarding the latest in Lyme disease
testing and treatment.
A Gold Award was presented to Quidel for its new series of
attention-grabbing educational videos called “Quick Takes.” This
soon-to-launch library of short and engaging videos, which will be
regularly produced in the coming months with breakwhitelight, will
help health care professionals and consumers alike enhance their
knowledge of Lyme disease by providing the information, expertise
and up-to-the-minute data needed to quickly and clearly confront
this disease that afflicts as many as 400,000 Americans every
year.
Quidel was also honored by MarCom for a commentary by Roxanne
Carfora, D.O., titled “An Epidemic Within a Pandemic.” Published in
the August 2020 issue of Healthcare Business Today, the article
calls Lyme disease one of the fastest-growing infectious diseases
in the country and speaks to the needed partnership between medical
science and consumers to understand the disease and to lessen its
spread.
Lyme disease can strike anyone at any age and can lead to a
number of serious, life-threatening problems if not caught early.
Leading the way in Lyme disease testing is Quidel’s innovative
Sofia 2 Lyme FIA test. This test provides a patient as well as his
or her physician with indicative results within minutes as opposed
to days, which has historically been the norm. Performed in the
privacy of a doctor’s office or local clinic, it is also the only
test that can get results from a simple finger prick of blood.
Given that the vast majority of patients tested are negative, not
having to wait days for test results allows physicians and nurse
practitioners to more rapidly treat those patients with positive
results while more quickly pursuing other diagnosis and treatment
for those who test negative.
About Quidel Corporation
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of
diagnostic solutions at the point of care, delivering a continuum
of rapid testing technologies that further improve the quality of
health care throughout the globe. An innovator for over 40 years in
the medical device industry, Quidel pioneered the first FDA-cleared
point-of-care test for influenza in 1999 and was the first to
market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted
brand names, Sofia®, Solana®, Lyra®, Triage® and QuickVue®,
Quidel’s comprehensive product portfolio includes tests for a wide
range of infectious diseases, cardiac and autoimmune biomarkers, as
well as a host of products to detect COVID-19. With products made
in America, Quidel’s mission is to provide patients with immediate
and frequent access to highly accurate, affordable testing for the
good of our families, our communities and the world. For more
information about Quidel, visit quidel.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201110005246/en/
Jim Yeager 424.644.0225 (office) 818.264.6812 (mobile)
jim@breakwhitelight.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From May 2024 to Jun 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
From Jun 2023 to Jun 2024